Gland Pharma Q4 Results Live : profit rise by 144.55% YOY
₹11.68, marking a 62.34% increase from the previous year.In terms of market performance, Gland Pharma delivered returns of 1.01% in the last week, 4.3% in the last 6 months, and -6.83% year-to-date.The company currently boasts a market capitalization of ₹29533.42 Cr with a 52-week high/low of ₹2194 & ₹896.5 respectively.Analysts covering Gland Pharma have mixed recommendations as of 23 May, 2024, with 3 analysts suggesting a Strong Sell, 1 analyst recommending Sell, 1 analyst opting for Hold, 3 analysts advising Buy, and 5 analysts advocating Strong Buy.
The overall consensus recommendation on the stock as of the same date was to Buy.FAQsQuestion : What is the Q4 profit/Loss as per company?Ans : ₹192.42CrQuestion : What is Q4 revenue?Ans : ₹1537.45CrStay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
